BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29330107)

  • 1. Prostate cancer-associated lncRNAs.
    Mitobe Y; Takayama KI; Horie-Inoue K; Inoue S
    Cancer Lett; 2018 Apr; 418():159-166. PubMed ID: 29330107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'?
    Walsh AL; Tuzova AV; Bolton EM; Lynch TH; Perry AS
    Trends Mol Med; 2014 Aug; 20(8):428-36. PubMed ID: 24836411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNAs in prostate cancer: Functional roles and clinical implications.
    Xu YH; Deng JL; Wang G; Zhu YS
    Cancer Lett; 2019 Nov; 464():37-55. PubMed ID: 31465841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lncRNAs in prostate cancer development and progression.
    Weiss M; Plass C; Gerhauser C
    Biol Chem; 2014 Nov; 395(11):1275-90. PubMed ID: 25153594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNAs and prostate cancer.
    Misawa A; Takayama KI; Inoue S
    Cancer Sci; 2017 Nov; 108(11):2107-2114. PubMed ID: 28796922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long non-coding RNAs in prostate cancer: An update].
    Wu PG; Zhang YX
    Zhonghua Nan Ke Xue; 2018 Aug; 24(8):735-739. PubMed ID: 30173435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA: A newly deciphered "code" in prostate cancer.
    Zhang A; Zhang J; Kaipainen A; Lucas JM; Yang H
    Cancer Lett; 2016 Jun; 375(2):323-330. PubMed ID: 26965999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long non-coding RNAs related to androgen receptor function in prostate cancer: Advances in studies].
    Wang M; Ying J; Zhang M; Liang CZ
    Zhonghua Nan Ke Xue; 2019 Aug; 25(8):739-743. PubMed ID: 32227719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a lncRNA-PCG bipartite network and identification of cancer-related lncRNAs: a case study in prostate cancer.
    Liu Y; Zhang R; Qiu F; Li K; Zhou Y; Shang D; Xu Y
    Mol Biosyst; 2015 Feb; 11(2):384-93. PubMed ID: 25385343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Potential Prostate Cancer-Related Pseudogenes Based on Competitive Endogenous RNA Network Hypothesis.
    Jiang T; Guo J; Hu Z; Zhao M; Gu Z; Miao S
    Med Sci Monit; 2018 Jun; 24():4213-4239. PubMed ID: 29923546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star.
    Xu T; Lin CM; Cheng SQ; Min J; Li L; Meng XM; Huang C; Zhang L; Deng ZY; Li J
    Mol Cancer; 2018 Jul; 17(1):103. PubMed ID: 30037351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
    Smolle MA; Bauernhofer T; Pummer K; Calin GA; Pichler M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.
    Ramnarine VR; Alshalalfa M; Mo F; Nabavi N; Erho N; Takhar M; Shukin R; Brahmbhatt S; Gawronski A; Kobelev M; Nouri M; Lin D; Tsai H; Lotan TL; Karnes RJ; Rubin MA; Zoubeidi A; Gleave ME; Sahinalp C; Wyatt AW; Volik SV; Beltran H; Davicioni E; Wang Y; Collins CC
    Gigascience; 2018 Jun; 7(6):. PubMed ID: 29757368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linc00963: a novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence.
    Wang L; Han S; Jin G; Zhou X; Li M; Ying X; Wang L; Wu H; Zhu Q
    Int J Oncol; 2014 Jun; 44(6):2041-9. PubMed ID: 24691949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative analysis reveals the dosage sensitivity and regulatory patterns of lncRNA in prostate cancer.
    Liu Y; Zhang R; Zhao N; Zhang Q; Yan Z; Chang Z; Wei Y; Wu C; Xu J; Xu Y
    Mol Biosyst; 2016 Oct; 12(10):3176-85. PubMed ID: 27507663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Landscape of Noncoding RNA in Prostate Cancer.
    Hua JT; Chen S; He HH
    Trends Genet; 2019 Nov; 35(11):840-851. PubMed ID: 31623872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?
    Deng J; Tang J; Wang G; Zhu YS
    Int J Environ Res Public Health; 2017 Mar; 14(3):. PubMed ID: 28272371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of prostate cancer LncRNAs by RNA-Seq.
    Hu CC; Gan P; Zhang RY; Xue JX; Ran LK
    Asian Pac J Cancer Prev; 2014; 15(21):9439-44. PubMed ID: 25422238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer.
    Li Y; Chen J; Zhang J; Wang Z; Shao T; Jiang C; Xu J; Li X
    Oncotarget; 2015 Sep; 6(28):25003-16. PubMed ID: 26305674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.